Family Medicine Doctors in Ripley, TN Accepting Medicare
3 Family Medicine doctors found. Showing 1 - 3
 Mr. Stephen Kenneth Goewey, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 326 Asbury Ave, Ste 101, Ripley, TN 38063 Phone: 731-221-1637 Fax: 731-221-3028 |
Joe W Hunt, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 202 Tucker Ave, Ripley, TN 38063 Phone: 731-635-4741 Fax: 731-635-3466 |
 Sarah Thompson Crawford, MSN,FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 79 Highway 51 S, Ripley, TN 38063 Phone: 731-635-8189 |
News Archive
Policy makers and experts to discuss future challenges in respiratory diseases
This lunchtime seminar entitled "Research and Respiratory Medicine: Addressing future challenges for improved lung health" is being organised by the European Respiratory Society in the context of 2010 the Year of the Lung and under the patronage of Prof. Ioannis A. Tsoukalas MEP and Ms. Satu Hassi MEP.
Bloodstream infections differ based on distance from the equator, health care spending
Where you live affects the type of bacteria that cause bloodstream infections, according to researchers at Rhode Island Hospital and an international team of investigators. The closer you live to the equator, the greater the likelihood of a bloodstream infection caused by a group of bacteria called Gram-negative bacteria, which thrive in warm and moist environments, compared to another group of bacteria referred to as Gram-positive bacteria.
Survey: Only 1 in 3 patients discusses symptoms of hyperglycaemia with nurse or doctor
Only 1 in 3 discussed symptoms of high blood glucose levels (hyperglycaemia) with their nurse or doctor, according to a new survey of 200 people living with type 1 or type 2 diabetes, who need mealtime insulin to control their blood glucose levels.
New clinical genomic testing helps identify mutations that drive childhood melanoma
Comprehensive clinical genomic testing of an adolescent patient, including whole genome sequencing, helped researchers identify mutations in a single gene that drive the most common childhood melanoma.
Enrollment complete in Rexahn's Serdaxin Phase IIb clinical trial for major depressive disorder
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has completed enrollment in its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).
› Verified 4 days ago